Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Gritstone Oncology Inc | 4 | 6 | 0 | 4 | €0.66 | €1.63 | 146.944% |
| Cara Therapeutics Inc. | 11 | 5 | 0 | 3 | €0.29 | €4.61 | 1496.327% |
| Savara Inc. | 4 | 2 | 3 | 2 | €3.40 | €5.00 | 47.059% |
| Owens & Minor Inc. | 2 | 2 | 0 | 1 | €14.10 | €24.04 | 70.512% |
| Trevena Inc. | 3 | 18 | 0 | 1 | €0.21 | €4.60 | 2089.286% |
| Ani Pharmaceuticals Inc. | 2 | 1 | 2 | 1 | €59.00 | €70.00 | 18.644% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.72 | - | - |
| Minerva Neurosciences Inc. | 0 | 6 | 0 | 0 | €2.98 | - | - |
| Coherus Bioscien. | 1 | 2 | 0 | 0 | €1.58 | - | - |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.84 | €5.51 | 559.641% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.44 | €18.37 | 1177.191% |
| T2 Biosystems Inc. | 0 | 8 | 0 | 0 | €0.16 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.05 | €7.31 | 139.607% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.22 | - | - |
| Sangamo Therapeutics Inc. | 12 | 12 | 0 | 0 | €0.37 | €3.63 | 877.694% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Pacific Biosciences of California Inc. | 10 | 5 | 0 | 0 | €1.27 | €10.05 | 693.595% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Nevro Corp. | 3 | 2 | 0 | 0 | €7.35 | €25.71 | 249.856% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.17 | €50.00 | 4162.575% |
| Anavex Life Sciences Corp | 1 | 2 | 1 | 0 | €4.01 | €5.50 | 37.055% |
| Agenus Inc. | 4 | 2 | 1 | 0 | €0.41 | €22.08 | 5234.848% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €1.17 | - | - |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €0.92 | €3.64 | 296.130% |